Explore the critical links between angina and heart disease in women in India, highlighting expert insights, health awareness ...

Explore how real-world evidence and biosimilars enhance insulin access and adherence, improving diabetes care and outcomes for patients who have type 2 diabetes.

The drug patents expired in India in July 2022, which has triggered a wave of generic launches and steep price corrections across the market.

Abbott and MSD Pharmaceuticals have partnered to distribute oral anti-diabetic medicines in India. Abbott will distribute MSD ...

Abbott and MSD Pharmaceuticals announced a partnership to distribute oral anti-diabetic medicines, specifically sitagliptin, ...

Abbott Labs received a confidence boost from Oppenheimer, which stuck to its $140 price target and Outperform rating. The ...

Controlling weight and cardiovascular risk factors is paramount in type 2 diabetes management; however, the definition and ...

According to Focus Report Store, the global homecare clinical nutrition market is growing at a CAGR of 7.34% during 2024-2030 ...

Both Fischel and La Bomba Pharmacies have asked their diabetic customers to schedule a free screening as part of a collaborative program where Ainnova will use its cutting-edge AI platform, Vision AI, ...

Abbott Laboratories (NYSE:ABT) is one of the best stocks to buy for beginners now. On June 10, Tandem Diabetes Care Inc.

Medtronic plc MDT announced on May 21 its plans to separate its Diabetes business into a separate, publicly traded company. The separation will occur via a two step transaction a ...